Horizon Therapeutics plc to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Horizon Therapeutics plc (Nasdaq: HZNP) will participate in two upcoming virtual investor conferences. Tim Walbert, CEO, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on January 6, 2022, at 9 a.m. ET. Additionally, at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, Walbert and Elizabeth H.Z. Thompson, EVP of Research and Development, will present at 11:15 a.m. ET. Both presentations will be webcast live on Horizon's website, with replays available after.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming virtual investor conferences:

Goldman Sachs 14^th Annual Healthcare CEOs Unscripted Conference: A View from the Top

Tim Walbert, chairman, president and chief executive officer, will present at 9 a.m. ET on Thursday, Jan. 6, 2022. The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available following the presentation.

40^th Annual J.P. Morgan Healthcare Conference

Tim Walbert, chairman, president and chief executive officer, and Elizabeth H.Z. Thompson, Ph.D., executive vice president, research and development, will present at 11:15 a.m. ET on Jan. 10, 2022. The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available following the event.

The Company suggests webcast participants sign on approximately 15 minutes in advance of each presentation to allow time to run a system test and download any free software needed for access purposes.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com, Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211222005516/en/

Investors:

Tina Ventura

Senior Vice President,

Investor Relations

investor-relations@horizontherapeutics.com



Ruth Venning

Executive Director,

Investor Relations

investor-relations@horizontherapeutics.com



U.S. Media:

Geoff Curtis

Executive Vice President,

Corporate Affairs & Chief Communications Officer

media@horizontherapeutics.com



Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

What is the date and time of Horizon Therapeutics' presentation at the Goldman Sachs Conference?

Horizon Therapeutics will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on January 6, 2022, at 9 a.m. ET.

Who will present at the J.P. Morgan Healthcare Conference for Horizon Therapeutics?

Tim Walbert and Elizabeth H.Z. Thompson will present at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 11:15 a.m. ET.

Where can I watch the Horizon Therapeutics conference presentations?

The presentations can be accessed live via Horizon Therapeutics' website, where replays will also be available.

What is Horizon Therapeutics focused on?

Horizon Therapeutics focuses on developing medicines for rare, autoimmune, and severe inflammatory diseases.

What is the stock symbol for Horizon Therapeutics?

The stock symbol for Horizon Therapeutics is HZNP.